Department Name

News and Events:

• UF receives $3 million grant to study type 1 diabetes
  The five-year NIH grant continues funding for studies aimed at preventing or delaying the onset of type 1 diabetes.

• UF shines blue for diabetes
  During November, the University of Florida will shine a “blue” spotlight on diabetes with several events planned to raise awareness and promote prevention of the disease.

• Scientists join forces to explain HIV spread in central and east Africa
  University of Florida scientists explain why two subtypes of HIV-1 -- the virus that causes acquired immunodeficiency syndrome, or AIDS -- held steady at relatively low levels for more than 50 years in west central Africa before erupting as an epidemic in east Africa in the 1970s.

• Soap-sniffing technology encourages hand washing to reduce hospital-acquired infections
  HyGreen hand hygiene system can help reduce infections and save money by reminding hospital workers to clean their hands to remove pathogens.

• Research suggests new cellular targets for HIV drug development
  Researchers identify new cellular target for HIV drug development.

• UF biologists join world experts in experiment to explore flu origins
  A UF evolutionary biology group joins other world experts in investigating the genetic origins of the current flu outbreak.

• UF researcher received national ‘Life Sciences’ award
  Bryon Petersen, an associate professor of pathology, received the Chairmen's Distinguished Life Sciences Award from the Christopher Columbus Fellowship Foundation and the U.S. Chamber of Commerce.

• UF researcher to probe evolution of HIV-related dementia
  Marco Salemi, Ph.D., an assistant professor in the department of pathology, immunology and laboratory medicine at the UF College of Medicine, has won a five-year, $3.5 million NIH grant to probe the genetic origins of HIV-associated dementia.

• UF diabetes researcher gets grant to fast-track discoveries
  COM researcher Chang-Qing Xia, Ph.D., receives funding from the Juvenile Diabetes Research Foundation allowing him to partner with industry to test a diabetes prevention therapy.